Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: one thing managment is definitely sharing with shareholders
S&L may not have a reason to drive the price down but driving the price down is simply a ramification of their business model. Sure - they'd love the price to skyrocket like the rest of us but they know it's not going to happen any time soon - so they make money while they can.
Share
New Message
Please login to post a reply